BUSINESS
Piramal Alternatives invests Rs 110 crore in Biodeal Pharmaceuticals
The strategic investment will fuel Biodeal's development of innovative solutions, enhance its production capabilities with advanced technology, and expand operations, positioning it as a leading nasal spray manufacturer
BUSINESS
RBI Monetary Policy | Private consumption looks set to gain steam soon: Governor Das
The central bank expects increased rural activity and consistent urban demand to boost consumption
BUSINESS
General Atlantic to acquire majority stake in hospital chain Ujala Cygnus
General Atlantic's former investments in India in the sector include Rubicon Research, ASG Eyecare and Hyderabad's KIMS Hospitals.
BUSINESS
Mankind Pharma to sell OTC business on a slump sale basis in yet-to-be subsidiary
Mankind's new subsidiary will have an initial paid-up capital of Rs 5 crore with a further investment of up to Rs 250 crore in one or more tranches, the press statement added.
BUSINESS
French pharma major Sanofi plans first-in-class drug launches in India
To bolster its market presence, Sanofi has entered into distribution agreements with prominent pharmaceutical companies such as Cipla, Dr Reddy’s, and Emcure Pharma
BUSINESS
Essential medicines to be slightly costlier from April 1
There are around 800 drugs on the National List of Essential Medicines maintained by the Department of Pharmaceuticals. The pricing is arrived at by the National Pharmaceutical Pricing Authority on the basis of the WPI of the previous calendar year.
BUSINESS
Narayana Health plans to roll out insurance service by Q1 of FY 25
The company’s planned capex of about Rs 1000 crore will be focused in India for the next few years, unlike the last year
BUSINESS
HealthQuad marks fourth exit from maiden fund; sells stake in Asian Institute of Nephrology and Urology
The VC fund plans to completely exit its first fund in the next 12-18 months. HealthQuad's second fund of $162 million has been deployed about 65-70 percent, so far, and it is currently looking to raise a third one with a targeted corpus of $300 million
BUSINESS
Why government is cracking down on junkets, gifts for doctors by pharma firms
The new rules state that pharma companies or their representatives should not offer hotel stays, expensive cuisine, etc, to healthcare professionals or their family members
BUSINESS
How a govt healthcare scheme is boosting pharma revenues
Jan Aushadhi Kendras procure medicines from private manufacturers and public sector drug manufacturers through an open tender system
BUSINESS
Biocon Biologics signs 10-year supply deal with Eris Lifesciences for Rs 1242 crore
As part of the deal over 430 employees associated with the business are expected to transition to Eris
BUSINESS
Hospital chain Paras Healthcare plans Rs 1,000 crore IPO; PE firm Creador to exit
Paras manages a portfolio of seven multi-super specialty hospitals across Haryana, Bihar, Rajasthan, J&K and Jharkhand with 1,700 beds.
_21405259.jpg "Government issues code to check unethical drug promotion")
BUSINESS
Government issues code to check unethical drug promotion
The code prohibits pharma companies from organising overseas workshops for healthcare professionals or providing them with accommodations, extravagant meals, or financial incentives
BUSINESS
Drugs controller orders immediate withdrawal of unapproved anti-bacterial drug
The drug can be used to treat bacterial diseases such as pneumonia, urinary tract infections, intra-abdominal infections, gynaecological infections, skin infections, meningitis, and sepsis
BUSINESS
Government announces revamped subsidy scheme to strengthen, upgrade pharma units
Under this scheme, pharma units can receive a maximum incentive of Rs 1 crore on an anticipated expense of Rs 150 crore. This will help the unit upgrade and meet the WHO GMP standards
BUSINESS
Indian pharma market registers 9% growth in February
Glaxo Smith Kline's antibiotic drug Augmentin and USV's anti-diabetes medication Glycomet GP continue to lead in sales.
BUSINESS
Healthcare innovation market in India could double to $60 billion by 2028: Bain & Co
Investor caution, driven by lengthy R&D cycles and monetisation processes, binary outcomes, and a lack of technical expertise, is undergoing transformation, said Bain. Twelve of the top 20 global Pharma firms have set up Global Capability Centres in India
BUSINESS
Suven-Cohance merged entity to have EBITDA margins in mid 30s: Management
In September 2023, the US-based private equity firm Advent acquired a controlling stake in Suven, expressing the intent to create a billion-dollar platform in the CDMO space.
BUSINESS
Experts argue against standardisation of rates for medical care
We should not turn the clock back towards a command-and-control economy with rationed services, says Viren Shetty of Narayana Health.
BUSINESS
Strong India growth, benign price erosion in the US drive Q3 earnings for Indian pharma
Indian generic companies have benefited from the continuing shortages and approval slowdown in the US.
BUSINESS
US FDA slaps Aurobindo Pharma's Telangana injectable facility with 7 observations
The company said that these observations are procedural in nature and will be responded to within the stipulated time.
BUSINESS
US FDA issues 4 observations for Biocon Biologics' insulin facility
The trigger for this inspection was a Pre-Approval Supplement (PAS) filed by BBL's customer late last year
BUSINESS
Diabetes, BP drugs to cost less as NPPA fixes retail prices of 69 formulations
Various drugs manufactured by listed players like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltda and Torrent Pharma are included in the list.
BUSINESS
What are nutraceuticals and why is government planning more regulations around them?
Though nutraceuticals are consumed widely, there is limited evidence of their health benefits in well-nourished adults. The government is planning tighter regulations on their quality, pricing and marketing aspects
